Author
Listed:
- Valeria Iansante
(Cell Signaling and Cancer Laboratory, Institute of Hepatology, Foundation for Liver Research)
- Pui Man Choy
(Cell Signaling and Cancer Laboratory, Institute of Hepatology, Foundation for Liver Research)
- Sze Wai Fung
(Section of Inflammation and Signal Transduction, Imperial College)
- Ying Liu
(The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine
Henan Cancer Hospital)
- Jian-Guo Chai
(Section of Molecular Immunology, Imperial College)
- Julian Dyson
(Section of Molecular Immunology, Imperial College)
- Alberto Del Rio
(Institute of Organic Synthesis and Photoreactivity, National Research Council)
- Clive D’Santos
(Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre)
- Roger Williams
(Cell Signaling and Cancer Laboratory, Institute of Hepatology, Foundation for Liver Research
Viral Hepatitis Laboratory, Institute of Hepatology, Foundation for Liver Research)
- Shilpa Chokshi
(Viral Hepatitis Laboratory, Institute of Hepatology, Foundation for Liver Research)
- Robert A Anders
(The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine)
- Concetta Bubici
(Section of Inflammation and Signal Transduction, Imperial College
Present address: Department of Life Sciences, Division of Biosciences, College of Health and Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK.)
- Salvatore Papa
(Cell Signaling and Cancer Laboratory, Institute of Hepatology, Foundation for Liver Research)
Abstract
Most tumour cells use aerobic glycolysis (the Warburg effect) to support anabolic growth and evade apoptosis. Intriguingly, the molecular mechanisms that link the Warburg effect with the suppression of apoptosis are not well understood. In this study, using loss-of-function studies in vitro and in vivo, we show that the anti-apoptotic protein poly(ADP-ribose) polymerase (PARP)14 promotes aerobic glycolysis in human hepatocellular carcinoma (HCC) by maintaining low activity of the pyruvate kinase M2 isoform (PKM2), a key regulator of the Warburg effect. Notably, PARP14 is highly expressed in HCC primary tumours and associated with poor patient prognosis. Mechanistically, PARP14 inhibits the pro-apoptotic kinase JNK1, which results in the activation of PKM2 through phosphorylation of Thr365. Moreover, targeting PARP14 enhances the sensitization of HCC cells to anti-HCC agents. Our findings indicate that the PARP14-JNK1-PKM2 regulatory axis is an important determinant for the Warburg effect in tumour cells and provide a mechanistic link between apoptosis and metabolism.
Suggested Citation
Valeria Iansante & Pui Man Choy & Sze Wai Fung & Ying Liu & Jian-Guo Chai & Julian Dyson & Alberto Del Rio & Clive D’Santos & Roger Williams & Shilpa Chokshi & Robert A Anders & Concetta Bubici & Salv, 2015.
"PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation,"
Nature Communications, Nature, vol. 6(1), pages 1-15, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8882
DOI: 10.1038/ncomms8882
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Ashna Dhoonmoon & Claudia M. Nicolae & George-Lucian Moldovan, 2022.
"The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO1,"
Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Chun Wai Wong & Christos Evangelou & Kieran N. Sefton & Rotem Leshem & Wei Zhang & Vishaka Gopalan & Sorayut Chattrakarn & Macarena Lucia Fernandez Carro & Erez Uzuner & Holly Mole & Daniel J. Wilcock, 2023.
"PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models,"
Nature Communications, Nature, vol. 14(1), pages 1-21, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8882. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.